Malate dehydrogenase, cytoplasmic
AltitudeomicsDB
Protein Official symbol |
MDH1 |
Aliases |
MDH1 MDHA |
Chromosomal Location |
2 |
Length |
334 |
Uniprot ID |
P40925 |
EC number |
1.1.1.37; 1.1.1.96 |
Protein family Information(Pfam) |
PF02866;PF00056; |
PDB id |
None |
InterPro ID |
IPR001557;IPR022383;IPR001236;IPR015955;IPR001252;IPR011274;IPR010945;IPR036291; |
dbSNP |
None |
AltitudeomicsDB
Protein 1 |
Protein 2 |
Combine Score |
FH |
MDH2 |
0.997 |
CS |
MDH2 |
0.997 |
CS |
ACLY |
0.995 |
GLUD2 |
GLUD1 |
0.9940000000000001 |
MDH1 |
MDH2 |
0.9940000000000001 |
FH |
CS |
0.9940000000000001 |
MDH2 |
GOT2 |
0.993 |
PC |
CS |
0.991 |
MDH1 |
GOT1 |
0.99 |
PC |
MDH2 |
0.99 |
PC |
PCK2 |
0.986 |
MDH1 |
CS |
0.986 |
GLUD1 |
GOT2 |
0.986 |
MDH1 |
FH |
0.983 |
PC |
ACLY |
0.98 |
PC |
ME1 |
0.9790000000000001 |
GOT1 |
GLUD1 |
0.9790000000000001 |
MDH1 |
GOT2 |
0.9790000000000001 |
PC |
PCK1 |
0.9790000000000001 |
ME1 |
MDH2 |
0.978 |
ME3 |
MDH2 |
0.978 |
GOT1 |
GLUD2 |
0.978 |
MDH2 |
ME2 |
0.977 |
MDH1 |
ME1 |
0.975 |
GLUD2 |
GOT2 |
0.973 |
ME3 |
PC |
0.972 |
MDH1 |
PC |
0.971 |
ME3 |
MDH1 |
0.971 |
MDH1 |
ME2 |
0.9690000000000001 |
ME1 |
FH |
0.9670000000000001 |
PC |
ME2 |
0.965 |
GOT1 |
MDH2 |
0.9640000000000001 |
FH |
ME2 |
0.9620000000000001 |
PC |
GOT1 |
0.96 |
ACLY |
PCK2 |
0.96 |
CS |
PCK2 |
0.96 |
MDH2 |
ACLY |
0.9590000000000001 |
MDH1 |
PCK2 |
0.9590000000000001 |
MDH1 |
ACLY |
0.9570000000000001 |
ME3 |
FH |
0.9570000000000001 |
MDH2 |
PCK2 |
0.9540000000000001 |
MDH1 |
PCK1 |
0.9540000000000001 |
PCK1 |
ACLY |
0.951 |
MDH2 |
GLUD1 |
0.946 |
PC |
GOT2 |
0.943 |
CS |
PCK1 |
0.9420000000000001 |
CS |
GOT2 |
0.94 |
MDH2 |
PCK1 |
0.9390000000000001 |
GLUD2 |
MDH2 |
0.937 |
MDH1 |
PGM1 |
0.934 |
MDH1 |
GLUD1 |
0.9309999999999999 |
GOT1 |
GOT2 |
0.9309999999999999 |
MDH1 |
SOD1 |
0.929 |
GOT1 |
FH |
0.929 |
CS |
GLUD1 |
0.9279999999999999 |
MDH1 |
UQCRFS1 |
0.9279999999999999 |
MDH2 |
UQCRFS1 |
0.927 |
ME1 |
CS |
0.9229999999999999 |
PC |
GLUD1 |
0.92 |
ME3 |
CS |
0.9179999999999999 |
GLUD1 |
ACLY |
0.914 |
CS |
GLUD2 |
0.912 |
FH |
GOT2 |
0.9109999999999999 |
MDH1 |
GLUD2 |
0.902 |
CS |
ME2 |
0.9009999999999999 |
Gene Ontology Semantic Similarity
Download Tab separated file
# |
55124 (PIWIL2) |
122402 (TDRD9) |
143689 (PIWIL4) |
91646 (TDRD12) |
84944 (MAEL) |
54514 (DDX4) |
136991 (ASZ1) |
3320 (HSP90AA1) |
54456 (MOV10L1) |
113802 (HENMT1) |
8468 (FKBP6) |
9271 (PIWIL1) |
55124 (PIWIL2)
|
1.00
|
0.12
|
1.00
|
0.26
|
0.57
|
0.12
|
0.19
|
0.28
|
0.40
|
0.23
|
0.30
|
0.83
|
122402 (TDRD9)
|
0.12
|
1.00
|
0.04
|
0.13
|
0.04
|
1.00
|
0.10
|
0.56
|
1.00
|
0.09
|
0.11
|
0.12
|
143689 (PIWIL4)
|
1.00
|
0.04
|
1.00
|
0.26
|
0.57
|
0.04
|
0.19
|
0.88
|
0.88
|
0.33
|
0.45
|
1.00
|
91646 (TDRD12)
|
0.26
|
0.13
|
0.26
|
1.00
|
0.26
|
0.13
|
0.64
|
0.48
|
0.28
|
0.48
|
0.48
|
0.48
|
84944 (MAEL)
|
0.57
|
0.04
|
0.57
|
0.26
|
1.00
|
0.04
|
0.19
|
0.66
|
0.66
|
0.33
|
0.45
|
0.57
|
54514 (DDX4)
|
0.12
|
1.00
|
0.04
|
0.13
|
0.04
|
1.00
|
0.10
|
0.56
|
1.00
|
0.09
|
0.11
|
0.12
|
136991 (ASZ1)
|
0.19
|
0.10
|
0.19
|
0.64
|
0.19
|
0.10
|
1.00
|
0.34
|
0.21
|
0.34
|
0.34
|
0.34
|
3320 (HSP90AA1)
|
0.28
|
0.56
|
0.88
|
0.48
|
0.66
|
0.56
|
0.34
|
1.00
|
0.42
|
0.49
|
0.56
|
0.56
|
54456 (MOV10L1)
|
0.40
|
1.00
|
0.88
|
0.28
|
0.66
|
1.00
|
0.21
|
0.42
|
1.00
|
0.22
|
0.31
|
0.47
|
113802 (HENMT1)
|
0.23
|
0.09
|
0.33
|
0.48
|
0.33
|
0.09
|
0.34
|
0.49
|
0.22
|
1.00
|
0.57
|
0.44
|
8468 (FKBP6)
|
0.30
|
0.11
|
0.45
|
0.48
|
0.45
|
0.11
|
0.34
|
0.56
|
0.31
|
0.57
|
1.00
|
0.58
|
9271 (PIWIL1)
|
0.83
|
0.12
|
1.00
|
0.48
|
0.57
|
0.12
|
0.34
|
0.56
|
0.47
|
0.44
|
0.58
|
1.00
|
Association with High Altitude
Protein Official symbol |
Source Organism |
Tissue of Expression |
Level of hypoxia |
Altitude |
Duration of experiment |
Level of expression |
Fold change |
Experiment details |
geographical location |
ethnicity of the patients |
Control group |
Control (Fold change) |
Reference (PMID) |
MDH1 |
Human |
Skeletal muscle |
- |
4559 m |
9 day |
downregulated |
-1.28 |
2-DIGE |
Southern Europe |
Italians |
1 |
Fasting control subjects at laboratory in Copenhagen with no caffeine intake |
18937252 |
Association with miRNA
miRTarBase ID |
miRNA |
Species (miRNA) |
Protein Official Symbol |
Human Entrez ID |
Species (Target Gene) |
Experiments |
Support Type |
References (PMID) |
MIRT028752 |
hsa-miR-26b-5p |
Homo sapiens |
MDH1 |
4190 |
Homo sapiens |
Microarray |
Functional MTI (Weak) |
19088304 |
MIRT045287 |
hsa-miR-186-5p |
Homo sapiens |
MDH1 |
4190 |
Homo sapiens |
CLASH |
Functional MTI (Weak) |
23622248 |
MIRT046497 |
hsa-miR-15b-5p |
Homo sapiens |
MDH1 |
4190 |
Homo sapiens |
CLASH |
Functional MTI (Weak) |
23622248 |
Gene Ontology
ID |
GO ID |
GO Term |
GO Type |
4190 |
GO:0006734 |
NADH metabolic process |
GOTERM_BP_DIRECT |
4190 |
GO:0005813 |
centrosome |
GOTERM_CC_DIRECT |
4190 |
GO:0006099 |
tricarboxylic acid cycle |
GOTERM_BP_DIRECT |
4190 |
GO:0016616 |
oxidoreductase activity |
GOTERM_MF_DIRECT |
4190 |
GO:0006108 |
malate metabolic process |
GOTERM_BP_DIRECT |
4190 |
GO:0051287 |
NAD binding |
GOTERM_MF_DIRECT |
4190 |
GO:0016615 |
glutamate binding |
GOTERM_MF_DIRECT |
4190 |
GO:0047860 |
arachidonate-CoA ligase activity |
GOTERM_MF_DIRECT |
4190 |
GO:0005739 |
mitochondrion |
GOTERM_CC_DIRECT |
4190 |
GO:0005737 |
cytoplasm |
GOTERM_CC_DIRECT |
4190 |
GO:0006094 |
gluconeogenesis |
GOTERM_BP_DIRECT |
4190 |
GO:0006107 |
oxaloacetate metabolic process |
GOTERM_BP_DIRECT |
4190 |
GO:0005515 |
protein binding |
GOTERM_MF_DIRECT |
4190 |
GO:0005829 |
cytosol |
GOTERM_CC_DIRECT |
4190 |
GO:0005975 |
carbohydrate metabolic process |
GOTERM_BP_DIRECT |
4190 |
GO:0005615 |
extracellular space |
GOTERM_CC_DIRECT |
4190 |
GO:0070062 |
extracellular exosome |
GOTERM_CC_DIRECT |
4190 |
GO:0004470 |
lactose synthase activity |
GOTERM_MF_DIRECT |
4190 |
GO:0030060 |
MHC class II protein complex binding |
GOTERM_MF_DIRECT |
4190 |
GO:0043209 |
myelin sheath |
GOTERM_CC_DIRECT |
Pathways
Human Entrez ID |
KEGG ID |
KEGG Term |
4190 |
hsa00020 |
Citrate cycle |
4190 |
hsa00270 |
Cysteine and methionine metabolism |
4190 |
hsa00620 |
Pyruvate metabolism |
4190 |
hsa00630 |
Glyoxylate and dicarboxylate metabolism |
4190 |
hsa01100 |
Metabolic pathways |
4190 |
hsa01130 |
Biosynthesis of antibiotics |
4190 |
hsa01200 |
Carbon metabolism |
4190 |
hsa04964 |
Proximal tubule bicarbonate reclamation |
Association with Disease
Protein Official Symbol |
Human Entrez ID |
Disease Name |
Disease Id |
Disease Semantic Type |
Semantic score |
DSI |
DPI |
Disease Type |
MDH1 |
4190 |
Hypertensive disease |
C0020538 |
Disease or Syndrome |
0.3 |
0.735 |
0.276 |
group |
MDH1 |
4190 |
Drug-Induced Acute Liver Injury |
C3658290 |
Disease or Syndrome |
0.3 |
0.735 |
0.276 |
disease |
MDH1 |
4190 |
Drug-Induced Liver Disease |
C0860207 |
Disease or Syndrome |
0.3 |
0.735 |
0.276 |
disease |
MDH1 |
4190 |
Hepatitis, Drug-Induced |
C1262760 |
Disease or Syndrome |
0.3 |
0.735 |
0.276 |
disease |
MDH1 |
4190 |
Chemical and Drug Induced Liver Injury |
C4277682 |
Disease or Syndrome |
0.3 |
0.735 |
0.276 |
disease |
MDH1 |
4190 |
Liver Cirrhosis, Experimental |
C0023893 |
Experimental Model of Disease |
0.3 |
0.735 |
0.276 |
disease |
MDH1 |
4190 |
Hepatitis, Toxic |
C0019193 |
Injury or Poisoning |
0.3 |
0.735 |
0.276 |
disease |
MDH1 |
4190 |
Respiratory Distress Syndrome, Adult |
C0035222 |
Disease or Syndrome |
0.3 |
0.735 |
0.276 |
disease |
MDH1 |
4190 |
Chemically-Induced Liver Toxicity |
C4279912 |
Disease or Syndrome |
0.3 |
0.735 |
0.276 |
disease |
MDH1 |
4190 |
Schizophrenia |
C0036341 |
Mental or Behavioral Dysfunction |
0.32 |
0.735 |
0.276 |
disease |
Association with Drug
Protein Official Symbol |
Human Entrez ID |
drug_claim_primary_name |
drug_name |
drug_chembl_id |
interaction_types |